Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle studies suggest that maintaining telomere length could help treat hair loss and graying, but it's uncertain if mouse results apply to humans.

Ceramide Synthase 4 is crucial for maintaining hair follicle stem cells and preventing hair loss.

Advancements in diagnostics, treatments, and technology have improved hair loss detection and restoration, with some types being reversible.

Keratin 15 helps maintain tissue integrity and is reduced in activated keratinocytes.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

The skin is a complex barrier that protects the body, regulates temperature, and helps with immune responses.

Th22 cells are essential for Tβ15-induced hair growth in mice.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Calcium signals and SHH guide the direction of feather growth in chicken skin.

Dupilumab may cause hair loss in some patients with severe atopic dermatitis.

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Dupilumab can help regrow hair in alopecia areata but stopping it may cause hair loss again.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Regulatory T cells are essential for normal and improved wound healing in mice.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

SH-340 may improve skin barrier and help treat atopic dermatitis.

Nanoparticle-based herbal remedies could be promising for treating hair loss with fewer side effects and lower cost, but more research is needed.

Old people have less hair because their hair follicles don't regenerate as well, not because of fewer stem cells, and a protein called follistatin might help reactivate hair growth.

Alopecia areata involves specific gene changes and immune pathways, offering new treatment targets.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Naringin may help treat atopic dermatitis by reducing inflammation and improving the skin barrier.